When your prescriber and the evidence disagree — that is the question, and I have not found it answered plainly anywhere I have looked.
What changes if the standard account of prescriber is wrong? I ask because I have been treating it as settled and I noticed this week that I could not say why.
Working through the consequences rather than the evidence, since others here are better placed on the evidence.
The opening post describes the usual case. This is about the unusual one.
How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this shows X benefit in people with my condition; would it be suitable for my specific situation?" That invites clinical reasoning rather than yes/no.
My position on prescriber is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
On post #2 — agreed on the reasoning, with one qualification.
Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
Confirming post #4 from a second method, which matters more than confirming it from a second person.
If you are new and reading this thread for the answer to prescriber: the answer is conditional, the conditions are in the third reply, and the rest of the thread is worth skipping.
A question phrased as "what would you want to see before considering X" is answerable and is not a request for X.
That is where I would start, not where I would stop.
Reframing prescriber slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how often", nobody here knows.
The documentation on prescriber is better than this thread and I say that as someone who has posted in the thread.
Coming back to post #9, because the follow-up matters more than the original answer.
Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and what the evidence basis is.
If you have been doing something the prescriber does not know about, saying so is more useful than not. Clinicians here consistently say they would rather know.
Clear enough that I do not think I have a follow-up, which is unusual.
I read post #14 twice before replying, because I had assumed the opposite.
If someone has run prescriber properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
Post #14 answers the question as asked. The question underneath it is different.
Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different paths have different implications.
A qualification I should have led with rather than closed on.
Where you disagree, saying so plainly and asking for the reasoning is better than agreeing and not following the plan.
The rule of thumb is fine; the edge cases are where it earns its keep.
Agreed on prescriber, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and the starting assumption is the part nobody states.
The question underneath prescriber is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it.
Write down what you would expect to see under each hypothesis before you collect anything. If they predict the same observation, collecting it will not help.
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
[2026 update] What a good consultation looks like from the other side
The question in the title: What a good consultation looks like from the other side I will give what I have already checked below so nobody repeats it. Good consultation: what I expected, what I found, and the…
|
+32 | 36 | 13k | 1mo |
|
Getting a referral rather than a refusal
Getting a referral rather than a refusal — setting out what I have, and where I think it stops being reliable. What changes if the standard account of getting a referral is wrong? I ask because I have been…
|
+8 | 12 | 32k | 2mo |
|
Coming back to: Preparing for an appointment: one page, three questions
Posting this under the heading it deserves: Preparing for an appointment: one page, three questions Everything below is what sits behind that. A question about how to describe something to a clinician rather…
|
+139 | 151 | 47k | 18mo |
|
What to bring: records that a clinician can actually use — a second dataset
What to bring: records that a clinician can actually use — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. A question about how to describe something…
|
+80 | 86 | 5.6k | 3h |
|
Second pass at: When your prescriber and the evidence disagree
Second pass at: When your prescriber and the evidence disagree — setting out what I have, and where I think it stops being reliable. What changes if the standard account of prescriber is wrong? I ask because…
|
+51 | 55 | 9.2k | 2d |
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Osteoarthritis and mechanical versus metabolic improvement
Osteoarthritis and mechanical versus metabolic improvement Writing it up because I had to work it out twice and would rather nobody else did. Asking about osteoarthritis and mechanical versus metabolic…
|
+2 | 6 | 30k | 12h |
|
Telehealth prescribing models in the US
Telehealth prescribing models in the US Writing it up because I had to work it out twice and would rather nobody else did. Trying to work out what would count as evidence on telehealth prescribing models,…
|
+95 | 102 | 6.1k | 14mo |
|
Second pass at: Coverage in the US: a map of the usual obstacles
On the subject in the title: Second pass at: Coverage in the US: a map of the usual obstacles Working notes rather than a conclusion. Two things I would like separated before anyone answers on Coverage,…
|
4 | 62k | 9mo | |
|
Canadian access and provincial variation
Posting this under the heading it deserves: Canadian access and provincial variation Everything below is what sits behind that. Trying to establish the boundary conditions on canadian access and provincial…
|
+74 | 80 | 7.7k | 18mo |
|
Personal import allowances, compared — a second dataset
Personal import allowances, compared — a second dataset — setting out what I have, and where I think it stops being reliable. Posting a small dataset on Personal import allowances. It is mine, it is…
|
+124 | 132 | 9.2k | 2mo |